Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Onco...

by Emily Hibbitts, Yueh‐Yun Chi, Douglas S. Hawkins, Frederic G. Barr, Julie A. Bradley, Roshni Dasgupta, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Sheri L. Spunt, Stephen X. Skapek, Suzanne L. Wolden, Carola A. S. Arndt
Published 2019-10-01

Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabd...

by Douglas J. Harrison, Yueh‐Yun Chi, Jing Tian, Pooja Hingorani, Leo Mascarenhas, Geoffrey B. McCowage, Brenda J. Weigel, Rajkumar Venkatramani, Suzanne L. Wolden, Torunn I. Yock, David A. Rodeberg, Andrea A. Hayes‐Jordan, Lisa A. Teot, Sheri L. Spunt, William H. Meyer, Douglas S. Hawkins, Barry L. Shulkin, Marguerite T. Parisi
Published 2021-02-01

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung

by Kristin Baird, John Glod, Seth M. Steinberg, Denise Reinke, Joseph G. Pressey, Leo Mascarenhas, Noah Federman, Neyssa Marina, Sant Chawla, Joanne P. Lagmay, John Goldberg, Mohammed Milhem, David M. Loeb, James E. Butrynski, Brian Turpin, Arthur Staddon, Sheri L. Spunt, Robin L. Jones, Eve T. Rodler, Scott M. Schuetze, Scott H. Okuno, Lee Helman
Published 2020-01-01